Evolus, Inc. (EOLS) Reports Break-Even Earnings for Q2

Impact · against what's priced in

Evolus (EOLS) shows improving operational efficiency by reaching break-even earnings and beating revenue estimates. While the stock has underperformed the S&P 500 this year, the trend toward profitability and consistent top-line growth provides a positive catalyst.

EOLS+0.40

No priced-in read yet

In context

The company shifted from a $0.24 per share loss last year to break-even earnings this quarter, beating the estimated $0.01 loss, while revenues grew to $84.08 million from $69.39 million.

Read from the article alone

• earnings
• healthcare
• EOLS
• earnings surprise
• medical products
• revenue

Search tags